Cannabis In Movement Disorders

Key Findings:  Despite the lack of controlled studies there is evidence that cannabinoids are of therapeutic value in the treatment of tics in Tourette syndrome, the reduction of levodopa-induced dyskinesia in Parkinson''s disease and some forms of tremor and dystonia. It can be speculated that cannabinoid antagonists might be useful in the treatment of chorea in Huntington''s disease and hypokinetic parkinsonian syndromes.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Ligands Studied:  Dopamine, GABA, Glutamate

Study Location(s):  Germany

Year of Pub:  1999

Link to study